Alpha Omega

Company Overview

Snapshot

Founded in April 1993 by Imad Younis and Reem Younis, Alpha Omega is a mature-stage company with over 500 employees. The company has secured $7 million in total capital across one funding round from Guangzhou Sino-Israel Biotech Investment Fund. In December 2018, Alpha Omega received a $7 million investment from Guangzhou Sino-Israel Biotech Investment Fund to establish a joint venture in China.

Business overview

Alpha Omega is a medical device company specializing in neurosurgery and neuroscience. The company develops sophisticated software and hardware for brain mapping and navigation, both during sleep and awake procedures, to enhance deep brain stimulation (DBS) therapy. Its solutions aim to increase treatment productivity for neurological and psychiatric disorders, ultimately improving patient outcomes. Alpha Omega operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, Medical Treatment & Therapeutics, and Diagnostics Devices, serving hospitals, laboratories, and academic researchers globally.

Strategic signal

In August 2024, Alpha Omega was featured for its expansion into Jenin, highlighting the company's commitment to growth and its unique position as an Arab-Israeli med-tech giant. This move signals a strategic geographic expansion and a continued focus on leveraging its technology in new markets, reinforcing its leadership in neurosurgical solutions.

Company Intelligence Q&A

When was Alpha Omega founded and by whom?

Alpha Omega was founded in April 1993 by Imad Younis and Reem Younis.

What was a significant partnership for Alpha Omega in 2019?

In April 2019, Alpha Omega signed a cooperation agreement with Medtronic to market its neurosurgery system globally. This deal was expected to generate millions in revenue and expand Alpha Omega's market reach.

What was the purpose of the $7 million investment in December 2018?

In December 2018, Alpha Omega received a $7 million investment from Guangzhou Sino-Israel Biotech Investment Fund (GIBF) to establish a joint venture in China, aimed at expanding the company's business in the region.

What is the significance of Alpha Omega's technology in brain surgeries?

Alpha Omega's technology assists in brain surgeries by providing sophisticated software and hardware for brain mapping and navigation, which is crucial for guiding electrodes in deep brain stimulation procedures and improving treatment outcomes for neurological and psychiatric disorders.